Found 24 matching trials
R-EPOCH in Combination With Ibrutinib for Patients With Classical RT of CLL PHASE2 This is an investigator-initiated Phase 2 study, which combines R-EDOCH wit...
Show More Location
Peking university Third Hospital
Learn More & Join Trial
CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma PHASE2 First-line CAR-T-cell consolidation after an abbreviated induction with 2 c...
Show More Location
University Hospital of Mainz
Learn More & Join Trial
Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury PHASE2 Coronavirus disease 2019 (COVID-19) is an infectious disease caused by seve...
Show More Location
Stanford University School of Med /ID# 221954
Learn More & Join Trial
National Project on Vaccines, COVID-19 and Frail Patients N/A This is a multicentre observational study with the aim of evaluating the an...
Show More Location
IRCCS Istituto Tumori Giovanni Paolo II
Learn More & Join Trial
MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas PHASE2 Single-arm, phase II clinical trial of patients with Extranodal Marginal Zo...
Show More Status
Active Not Recruiting
Location
CHU UCL Namur / site Godinne
Learn More & Join Trial
Sequential Regimen of Bendamustin [B] Followed by GA101 and Ibrutinib [I] in CLL Patients PHASE2 A prospective, open-label, multicenter Phase-II trial to evaluate the effic...
Show More Location
German CLL Study Group
Learn More & Join Trial
Combination of PCI-32765 With Obinutuzumab in Untreated Follicular Lymphoma PHASE2 Primary Objectives The primary objective of this study is to evaluate the e...
Show More Location
Klinikum der Universität München
Learn More & Join Trial
LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV) PHASE1 This study is to improve the first-line induction chemotherapy, by combinin...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Prospective Multicenter Phase 2 Study of FCR/BR Alternating With Ibrutinib in Treatment-naive Patients With CLL PHASE2 This is a prospective multicenter phase 2 study designed with the purpose t...
Show More Location
Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College
Learn More & Join Trial
Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT PHASE2 Multicentric phase II trial to evaluate efficacy and safety of ibrutinib in...
Show More Location
Hospital Universitario Son Espases
Learn More & Join Trial